Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) is set to participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, at 7:00 AM ET. The presentation will be virtual, and investors can access the pre-recorded audio via the company's website. Pacira is recognized for its leadership in non-opioid pain management, particularly through its long-acting local analgesic, EXPAREL®, which launched in April 2012. The company also acquired the iovera°® system in 2019 to enhance its offerings in regenerative health solutions.

PARSIPPANY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the H.C. Wainwright 23^rd Annual Global Investment Conference at 7:00 AM ET on Monday, September 13, 2021. Pre-recorded audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

FAQ

When is Pacira BioSciences presenting at the H.C. Wainwright conference?

Pacira BioSciences will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, at 7:00 AM ET.

How can I access Pacira's presentation at the investment conference?

You can access the pre-recorded audio of Pacira's presentation by visiting the 'Events' page on the company's website.

What products does Pacira BioSciences focus on?

Pacira BioSciences focuses on non-opioid pain management solutions, including its long-acting local analgesic, EXPAREL®, and the iovera°® cryoanalgesia device.

What is EXPAREL® and when was it launched?

EXPAREL® is a long-acting local analgesic launched in April 2012, designed to improve pain management without opioids.

What is the iovera°® system acquired by Pacira?

The iovera°® system is a handheld cryoanalgesia device that delivers controlled doses of cold temperature to targeted nerves.